Larsen E, Perez-Atayde A, Green D M, Retik A, Clavell L A, Sallan S E
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115.
Cancer. 1990 Jul 15;66(2):264-6. doi: 10.1002/1097-0142(19900715)66:2<264::aid-cncr2820660212>3.0.co;2-z.
A prospective pilot study was undertaken to examine the outcome of patients with Stage I (Cassady) Wilms' tumor treated with nephrectomy only. Eight consecutive patients fulfilling the criteria for Stage I (Cassady) Wilms' tumor (age less than 2 years with unilateral, nonmetastatic, favorable histopathologic type, and tumor weight less than 550 g) underwent nephrectomy with no further therapy. All eight patients were alive and free of disease with a mean follow-up period of 5 years. There was one tumor recurrence that involved a metachronously occurring bilateral tumor. Overall survival (100%) and event-free survival (88%) were comparable with clinical trials in which patients received adjuvant therapy. Patients with Stage I (Cassady) Wilms' tumor can be successfully treated with nephrectomy alone, thereby eliminating the toxicity of adjuvant therapy.
开展了一项前瞻性试验研究,以检查仅接受肾切除术治疗的I期(卡萨迪分期)威尔姆斯瘤患者的治疗结果。连续8例符合I期(卡萨迪分期)威尔姆斯瘤标准(年龄小于2岁,单侧、无转移、组织病理学类型良好,肿瘤重量小于550克)的患者接受了肾切除术,未接受进一步治疗。所有8例患者均存活且无疾病,平均随访期为5年。有1例肿瘤复发,为异时性双侧肿瘤。总生存率(100%)和无事件生存率(88%)与患者接受辅助治疗的临床试验相当。I期(卡萨迪分期)威尔姆斯瘤患者仅通过肾切除术即可成功治疗,从而消除辅助治疗的毒性。